These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32473073)

  • 1. Invasive Lactococcus lactis producing mycobacterial Hsp65 ameliorates intestinal inflammation in acute TNBS-induced colitis in mice by increasing the levels of the cytokine IL-10 and secretory IgA.
    da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
    J Appl Microbiol; 2020 Nov; 129(5):1389-1401. PubMed ID: 32473073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterial Hsp65 antigen delivered by invasive Lactococcus lactis reduces intestinal inflammation and fibrosis in TNBS-induced chronic colitis model.
    da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
    Sci Rep; 2020 Nov; 10(1):20123. PubMed ID: 33208841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis.
    Zurita-Turk M; Del Carmen S; Santos AC; Pereira VB; Cara DC; Leclercq SY; de LeBlanc Ad; Azevedo V; Chatel JM; LeBlanc JG; Miyoshi A
    BMC Biotechnol; 2014 Aug; 14():73. PubMed ID: 25106058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells.
    Souza BM; Preisser TM; Pereira VB; Zurita-Turk M; de Castro CP; da Cunha VP; de Oliveira RP; Gomes-Santos AC; de Faria AM; Machado DC; Chatel JM; Azevedo VA; Langella P; Miyoshi A
    Microb Cell Fact; 2016 Aug; 15(1):150. PubMed ID: 27576902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Tolerance Induced by Heat Shock Protein 65-Producing
    Guerra PV; Andrade CM; Nunes IV; Gama BC; Tibúrcio R; Santos WLC; Azevedo VA; Tavares NM; Rebouças JS; Maiolii TU; Faria AMC; Brodskyn CI
    Front Immunol; 2021; 12():647987. PubMed ID: 34248935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
    Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
    Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant
    Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
    J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp65-Producing
    Gusmao-Silva G; Aguiar SLF; Miranda MCG; Guimarães MA; Alves JL; Vieira AT; Cara DC; Miyoshi A; Azevedo VA; Oliveira RP; Faria AMC
    Front Immunol; 2020; 11():562905. PubMed ID: 33072101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells.
    Rezende RM; Oliveira RP; Medeiros SR; Gomes-Santos AC; Alves AC; Loli FG; Guimarães MA; Amaral SS; da Cunha AP; Weiner HL; Azevedo V; Miyoshi A; Faria AM
    J Autoimmun; 2013 Feb; 40():45-57. PubMed ID: 22939403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of intestinal inflammation in IL-10 deficient mice by a plasmid carrying Lactococcus lactis strain.
    Zurita-Turk M; Mendes Souza B; Prósperi de Castro C; Bastos Pereira V; Pecini da Cunha V; Melo Preisser T; Caetano de Faria AM; Carmona Cara Machado D; Miyoshi A
    BMC Biotechnol; 2020 Jul; 20(1):38. PubMed ID: 32703192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Jing H; Yong L; Haiyan L; Yanjun M; Yun X; Yu Z; Taiming L; Rongyue C; Liang J; Jie W; Li Z; Jingjing L
    Vaccine; 2011 May; 29(24):4102-9. PubMed ID: 21497632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice.
    Ma Y; Liu J; Hou J; Dong Y; Lu Y; Jin L; Cao R; Li T; Wu J
    PLoS One; 2014; 9(8):e105701. PubMed ID: 25157497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A.
    de Azevedo M; Karczewski J; Lefévre F; Azevedo V; Miyoshi A; Wells JM; Langella P; Chatel JM
    BMC Microbiol; 2012 Dec; 12():299. PubMed ID: 23253484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10-producing Lactococcus lactis using a murine model of Crohn's disease.
    del Carmen S; de Moreno de LeBlanc A; Perdigon G; Bastos Pereira V; Miyoshi A; Azevedo V; LeBlanc JG
    J Mol Microbiol Biotechnol; 2011; 21(3-4):138-46. PubMed ID: 22286041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells.
    Innocentin S; Guimarães V; Miyoshi A; Azevedo V; Langella P; Chatel JM; Lefèvre F
    Appl Environ Microbiol; 2009 Jul; 75(14):4870-8. PubMed ID: 19482952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+.
    Pereira VB; Saraiva TD; Souza BM; Zurita-Turk M; Azevedo MS; De Castro CP; Mancha-Agresti P; Dos Santos JS; Santos AC; Faria AM; Leclercq S; Azevedo V; Miyoshi A
    Appl Microbiol Biotechnol; 2015 Feb; 99(4):1817-26. PubMed ID: 25503506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice.
    Shigemori S; Watanabe T; Kudoh K; Ihara M; Nigar S; Yamamoto Y; Suda Y; Sato T; Kitazawa H; Shimosato T
    Microb Cell Fact; 2015 Nov; 14():189. PubMed ID: 26608030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peyer's Patches as a Portal for DNA Delivery by Lactococcus lactis in Vivo.
    Yano A; Takahashi K; Mori Y; Watanabe S; Hanamura Y; Sugiyama T; Inoue N
    Biol Pharm Bull; 2018; 41(2):190-197. PubMed ID: 29386479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.
    Bermúdez-Humarán LG; Motta JP; Aubry C; Kharrat P; Rous-Martin L; Sallenave JM; Deraison C; Vergnolle N; Langella P
    Microb Cell Fact; 2015 Feb; 14():26. PubMed ID: 25889561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
    del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
    J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.